We studied the effects of intense sympathetic stimulation on the chronotropic responses of the heart to subsequent test stimulations of the cardiac autonomic nerves in dogs anesthetized with a-chloralose. Such intense sympathetic stimulations (which we refer to as "release stimulations") are diminishes the release of NE evoked by sympathetic stimulation in perfused guinea pig hearts,19 in isolated guinea pig atria," and in isolated human submandibular arteries.20 However, these effects of NPY on sympathetic neurotransmission were either produced by exogenous neuropeptide Y or elicited in blood vessels in vitro. Therefore, whether sufficient quantities of NPY are released from the sympathetic nerve endings to influence sympathetic neurotransmission appreciably under more physiological conditions is still uncertain.
Sympathetic nerve fibers, including those that innervate the heart, release not only norepinephrine (NE) but also certain neuropeptides, especially neuropeptide Y (NPY).1-3 NPY and NE are released together from sympathetic nerves in response to spontaneous neural activity,4'5 to electrical stimulation of the cardiac nerve trunks,67 or to field stimulation of the sympathetic nerve fibers in isolated blood vessels. [8] [9] [10] NPY may act postjunctionally to affect the mechanical and electrophysiological properties of cardiac tissues.1-13 However, its principal cardiac action appears to be mediated prejunctionally; i.e., it modulates the release of various neurotransmitters from autonomic nerve endings. NPY attenuates the vagal effects on heart rate, atrioventricular conduction, and atrial contractility,7'14-'8 presumably by inhibiting the release of acetylcholine from vagal nerve endings.15 NPY also modulates sympathetic neurotransmission, but its physiological role is not well established. Exogenous NPY diminishes the release of NE evoked by sympathetic stimulation in perfused guinea pig hearts,19 in isolated guinea pig atria," and in isolated human submandibular arteries. 20 However, these effects of NPY on sympathetic neurotransmission were either produced by exogenous neuropeptide Y or elicited in blood vessels in vitro. Therefore, whether sufficient quantities of NPY are released from the sympathetic nerve endings to influence sympathetic neurotransmission appreciably under more physiological conditions is still uncertain.
The present experiments were designed to determine whether an antecedent period of intense sympathetic stimulation, presumably by releasing NPY, inhibits cardiac sympathetic neurotransmission in vivo. We compared the observed effects on sympathetic neurotransmission with those on cardiac vagal neurotransmission, because substantial evidence has already been accrued to show that such intense sympathetic stimulations, probably by releasing NPY, do inhibit vagal neurotrans- Figure 1A ) and sympathetic (S1-S3) test These stimulations consisted of 30-second trains of electrical pulses, each 1 msec in duration, supramaximal in voltage, and delivered at a frequency of 3 Hz. We used the chronotropic responses (i.e., the changes in cardiac cycle lengths) to the vagal and sympathetic test stimuli as indexes of parasympathetic and sympathetic neurotransmission .
After we had recorded the control responses to the test stimulations, we delivered a single 5-minute train of intense bilateral sympathetic stimulation (15 V, 30 Hz, 1-msec pulse width) to release appreciable quantities of NPY from the sympathetic nerve endings in the heart ( Figure 1A ). We will refer to this intense stimulation as a sympathetic "release" stimulation. To assess the effects of the release stimulation on subsequent vagal and sympathetic neurotransmission, we again measured the chronotropic responses to periodic vagal (V4, V5, . . .) and sympathetic (S4, S5, . . .) test stimulations until the responses returned to their respective control levels.
In a second subgroup of animals (n=6), we implemented an abridged protocol similar to that shown in Figure 1A . The principal difference was that we interposed a sham, rather than an actual, sympathetic release stimulation. The purpose of this sham stimulation experiment was to determine whether the sympathetic test stimulations that were given before the release stimulation exerted any detectable effects on the responses to the sympathetic test stimulations that followed the release stimulation.
Series 2: Effects of the frequency and duration of the sympathetic release stimulations and of a-adrenergic receptor blockade. Animals were assigned randomly either to a control group (n = 6) or to a group that received phentolamine (n =5); no animal was assigned to both groups. Each experiment, regardless of the group, was divided into two observation periods. Each period included four stimulation regimens (each similar to that shown in Figure 1A ). In two of the regimens, the sympathetic release stimulations were 1 minute in duration (D,), and in the other two, they were Figure 1A . For each stimulation regimen, we waited for the test stimulation responses after the release stimulation to recover to at least 95% of the control (prerelease) responses before we began the next stimulation regimen.
During period 1, the test stimulation regimens were identical, regardless of the group. In the phentolamine group, a bolus of phentolamine (2 mg/kg) was given intravenously at the beginning of period 2, and a supplemental infusion of 1 mg/kg per hour was given throughout that period. In this group, period 1 served as an internal control for the effects of phentolamine. The control group did not receive phentolamine, but these animals were given an equivalent volume of saline. In this group, we compared the responses in periods 1 and 2 to assess the changes in the cardiac responses over the elapsed time between periods. Series 3: Effects on the chronotropic responses to isodesigned to determine whether intense sympathetic stimulation, presumably by releasing NPY, affects sympathetic neurotransmission by inhibiting the responsiveness of the cardiac effector cells to ,B-adrenergic agonists. Animals were assigned randomly to a sympathetic release stimulation group (n = 6) or to a sham stimulation group (n =3). During a control period in the release stimulation group, we measured the chronotropic responses to two vagal test stimulations and to two ISO infusions ( Figure 1B ). The vagal test stimulations and the sympathetic release stimulations were identical to those described in series 1. Beginning 10 seconds after cessation of the first vagal test stimulation (V,), we began to infuse ISO (ISO1, 0.1 ug/kg) intravenously at a constant rate for 1 minute. The second vagal test stimulation (V2) was delivered 10 minutes after the first vagal test stimulation, and V2 was followed immediately by a second ISO infusion (ISO2). Ten minutes after the cessation of IS02, we delivered the sympathetic release stimulation (15 V, 30 Hz, 1-msec pulse width, for 5 minutes). In the sham group, we did not stimulate the sympathetic nerves, but we allowed the same time to elapse as in the release stimulation group before we tested the subsequent responses to vagal test stimuli and to ISO infusions.
After the sympathetic release or the sham stimulation, we again measured the chronotropic responses to two vagal test stimulations (V3 and V4) at 5 and 15 minutes after cessation of the release stimulation and to one ISO infusion (IS03) that was begun 10 seconds after cessation of V3 ( Figure 1B ). The responses to the ISO infusions required 10 minutes or more to recover; therefore, we determined the response to only one ISO infusion after the sympathetic release stimulation. By 15 minutes after cessation of the release stimulation, its inhibitory effects on sympathetic neurotransmission would have diminished by over 50% (as shown in Figure 4 ). Figure 2 shows the changes in cardiac cycle length (AA interval) evoked by the vagal and sympathetic test stimulations in the first series of experiments. Before the sympathetic release stimulation (Figure 2A) Figure  2B ). We will call the chronotropic response to the first postrelease test stimulation the "initial response" (Rj). After the release stimulation, the vagal and sympathetic test stimuli were applied every 2.5 minutes (Figure 1A) We refer to the area between a recovery curve and the horizontal line that represents the mean control response (100%) as the "summated response." The summated response represents the effect of the sympathetic release stimulation on the chronotropic responses to vagal or sympathetic test stimulations, integrated over the entire time course of that effect. Thus, the summated response conveys information not only about the magnitude but also about the duration of the response. The shaded area in Figure 3 Figure 7 . In the release stimulation group, the mean±SEM control AA interval was 614±17 msec.
Results

Representative Experiment
Before the release stimulation, ISO Sham Stimulation Release Stimulation lations (302±93 msec) were substantially less than the control responses (p<0.001). Before the sham stimulations ( Figures 7A and 7C ), the ISO infusions decreased the AA intervals by 169±58 msec, and the vagal test stimulations increased the AA intervals by 680±76 msec. The chronotropic responses to these interventions after the sham stimulations did not differ significantly from those elicited before the sham stimulations. Discussion Potter14'5 was the first investigator to characterize the sustained inhibitory effects of intense sympathetic stimulation on the cardiac chronotropic responses to subsequent vagal test stimulations. The inhibitory effects of sympathetic release stimulation on the responses to subsequent vagal test stimulations in our present experiments confirm Potter's observations14,15 and also confirm previous observations from our laboratory.7 '16"17 These enduring inhibitory effects of sympathetic release stimulation on vagal neurotransmission7'14-17 cannot be ascribed to the NE released during the antecedent sympathetic release stimulation. The administration of exogenous NE does not persistently inhibit the chronotropic responses to vagal test stimulations. ' 4 Conversely, an intravenous injection of NPY does inhibit vagal neurotransmission persistently.14'1517 NPY is known to be released along with NE from the sympathetic nerve endings.4-10 These findings suggest, therefore, that the prolonged attenuation of the vagal responses may be mediated by neurally released NPY. Potter's experiments14"15 showed that exogenous NPY did not alter the chronotropic responses to a musearinic agonist,"5 and she concluded that NPY, released during intense sympathetic stimulation, persistently depresses vagal neurotransmission by inhibiting the release of acetylcholine from the vagal nerve endings.'4 Although her conclusions and those of subsequent investigators are based on substantial physiological and pharmacological evidence, they cannot yet be considered established, because a potent, highly specific antagonist to NPY has not been available.
In the present study, we used an experimental protocol similar to that designed by Potter14"15 to determine whether cardiac sympathetic neurotransmission is also inhibited by intense sympathetic stimulation. Abundant evidence already indicates that NPY may interact with NPY receptors on the sympathetic nerve endings to suppress the release of NE from those nerve endings. Exogenous NPY decreases the stimulation-evoked release of NE in the perfused guinea pig heart,'9 in guinea pig atria," and in isolated human submandibular arteries. 20 These findings suggest that NPY may inhibit sympathetic neurotransmission, at least in part, by suppressing the release of NE from the sympathetic nerve endings. However, these previous experiments involved isolated tissue preparations or the administration of exogenous NPY. Therefore, it had not yet been established whether sufficient NPY was released from the cardiac sympathetic nerves in situ to affect cardiac sympathetic neurotransmission.
In the present study, we determined the effects of neurally released NPY on sympathetic neurotransmission in a much more intact preparation than had been used previously. We observed that intense sympathetic stimulation persistently inhibited the chronotropic responses to sympathetic as well as to vagal test stimulations (Figures 2-4) . However, the effects on the sympathetic responses were less pronounced than were those on the vagal responses (Figures 2-4) . The attenuation varied directly with the frequency and duration of the sympathetic release stimulation ( Figure 5) . The initial and summated responses to sympathetic test stimulations were inhibited significantly, even when the sympathetic release stimulations were delivered for only 1 minute at 5 Hz (Figures 5 and 6) .
The attenuation of sympathetic neurotransmission in our experiments might have been produced, at least partly, by a depletion of the releasable pool of NE in the sympathetic nerve terminals during the antecedent period of intense sympathetic stimulation or by direct damage to the nerve fibers. We would anticipate, however, that such processes would be minimal and transient. The sympathetic nerve terminals are able to synthesize NE, to adjust the rate of synthesis to the rate of neural activity, and to take up much of the released NE. 23 The accentuated inhibition of the chronotropic responses to the sympathetic test stimulations by phentolamine ( Figures 5 and 6 ) parallel our previous observations16 '17 that phentolamine significantly augmented the inhibitory effects of intense sympathetic stimulation on vagal neurotransmission. Activation of a-adrenergic receptors on the sympathetic nerve endings inhibits the release of NPY and of NE from those nerve endings, and a-adrenergic receptor blockade enhances the release of these mediators.6'28 '29 Potter'5 attempted to determine whether the attenuation of the vagal effects on heart rate induced by intense sympathetic stimulation was mediated prejunctionally (by a reduction in acetylcholine release) or postjunctionally (by a reduction in the responsiveness of the sinoatrial node cells). She found that, in anesthetized dogs, neither intense sympathetic stimulation (which releases NPY) nor exogenous NPY altered the chronotropic responses to a muscarinic agonist.'5 Thus, the effect of intense sympathetic stimulation on parasympathetic neurotransmission appeared to be prejunctional. We used a similar strategy in the present experiments to assess whether sympathetic release stimulation affected sympathetic neurotransmission prejunctionally or postjunctionally. We tried to distinguish whether the attenuation of the responses to sympathetic test stimulations (Figures 2-4 ) evoked by sympathetic release stimulation was induced 1) by a diminished neuronal release of NE during the postrelease sympathetic test stimulations or 2) by a diminished responsiveness of the cardiac pacemaker cells to ,B-adrenergic agonists.
In our experiments in series 3, the responses to ISO infusions were not affected by the antecedent sympathetic release stimulation ( Figure 7B ). Hence, either the NPY released by the intense sympathetic stimulation did not alter the sensitivity of the cardiac pacemaker cells to ,B-adrenergic agonists, or our intense sympathetic stimulations did not release appreciable quantities of NPY in this series of experiments. With regard to the first of these alternatives, Franco-Cereceda et al"l observed responses that paralleled our results; they found that exogenous NPY did not affect the response of the guinea pig atrium to NE.
With regard to the second alternative proposed above, we used the cardiac responses to the vagal test stimulations as an index of the quantity of NPY released by our sympathetic stimulations. A recent study7 from our laboratory demonstrated that the overflow of NPY into the coronary sinus blood in response to stimulation of the cardiac sympathetic nerves correlated well with the subsequent attenuation of vagal neurotransmission elicited by that sympathetic stimulation. The results of our present experiments showed that the chronotropic responses to the vagal test stimulations were significantly attenuated after sympathetic release stimulation ( Figure 7D ). The sustained attenuation of the vagal responses suggests that NPY was indeed released by the intense sympathetic stimulation. Our present experiments also showed that the chronotropic responses to ISO infusions were not appreciably affected by intense sympathetic release stimulation ( Figure 7D ). The most likely conclusion, therefore, is that the NPY released by intense sympathetic stimulation acts prejunctionally to suppress the subsequent release of NE from the sympathetic nerve endings, just as it acts prejunctionally to suppress the release of acetylcholine from the parasympathetic nerve endings. However, the conclusion that these phenomena are mediated by NPY will probably not be established unequivocally until a specific and potent NPY antagonist becomes available.
